Parra Raul Jr. 4
4 · MERIT MEDICAL SYSTEMS INC · Filed Nov 12, 2024
Insider Transaction Report
Form 4
Parra Raul Jr.
CFO AND TREASURER
Transactions
- Sale
Common Stock, No Par Value
2024-11-07$102.18/sh−5,361$547,787→ 16,361 total - Exercise/Conversion
Non-qualified stock options (right to buy)
2024-11-07−5,361→ 5,361 totalExercise: $37.71From: 2021-02-26Exp: 2027-02-26→ Common Stock (5,361 underlying) - Exercise/Conversion
Common Stock, No Par Value
2024-11-07$37.71/sh+5,361$202,163→ 21,722 total
Holdings
- 9,681
Non-qualified stock options (right to buy)
Exercise: $56.25From: 2022-03-19Exp: 2028-03-19→ Common Stock (9,681 underlying) - 2,770(indirect: By 401(k))
Common Stock, No Par Value
- 14,570
Non-qualified stock options (right to buy)
Exercise: $65.03From: 2023-02-28Exp: 2029-02-28→ Common Stock (14,570 underlying) - 13,576
Non-qualified stock options (right to buy)
Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (13,576 underlying)
Footnotes (6)
- [F1]Represents plan holdings as of 11/07/2024.
- [F2]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.17 to $102.25, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F3]Becomes exercisable in equal annual installments of 25% commencing 02/26/2021.
- [F4]Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
- [F5]Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
- [F6]Becomes exercisable in equal annual installments of 25% commencing on 02/28/2024.